INKON Life Technology Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 26, 2021 at 08:02 am EDT
Share
INKON Life Technology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 298.741 million compared to CNY 283.379 million a year ago. Operating income was CNY 38.012 million compared to CNY 42.044 million a year ago. Net income was CNY 23.649 million compared to CNY 26.925 million a year ago. Basic earnings per share from continuing operations was CNY 0.0369 compared to CNY 0.0493 a year ago.
INKON Life Technology Co., Ltd., formerly Starmap medicine & technology Co., Ltd., is a China-based company principally engaged in providing medical services. Its medical services focus on cancer prevention, diagnosis, treatment and rehabilitation. The Company is also engaged in the research and development, manufacture and sales of medical equipment, as well as medical software development. Its medical equipment mainly include MASEP digital radiotherapy equipment, MASEP Gamma Knife and other large medical equipment. The Company distributes its products within domestic market and to overseas markets.
INKON LIFE TECHNOLOGY CO., LTD. 
